Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/NMD.0000000000001318 http://scihub22266oqcxt.onion/10.1097/NMD.0000000000001318 33625069!ä!33625069 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Nerv+Ment+Dis 2021 ; 209 (4): 256-264 Nephropedia Template TP {{tp|p=33625069|t=2021. Impact of the COVID-19 Pandemic on the Short-Term Course of Obsessive-Compulsive Disorder |pdf=|usr=}}{{33625069}} gab.com Text Impact of the COVID-19 Pandemic on the Short-Term Course of Obsessive-Compulsive Disorder JO: J Nerv Ment Dis http://www.kidney.de/pget.php?&tw=1&pmid=33625069 #FOAvip There is an understandable concern that obsessive-compulsive disorder (OCD) may worsen during the COVID-19 pandemic, but there are little empirical data. We report the impact of COVID-19 pandemic on the short-term course of OCD. A cohort of patients with a primary diagnosis of OCD (n = 240) who were on regular follow-up at a tertiary care specialty OCD clinic in India were assessed telephonically, about 2 months after the declaration of the pandemic ("pandemic" cohort). Data from the medical records of an independent set of patients with OCD (n = 207) who were followed up during the same period, 1 year prior, was used for comparison (historical controls). The pandemic group and historical controls did not differ in the trajectories of the Yale-Brown Obsessive-Compulsive Scale scores (chi-square likelihood ratio test of the group x time interaction = 2.73, p = 0.255) and relapse rate (21% vs. 20%; adjusted odds ratio, 0.81; 95% confidence interval, 0.41-1.59; p = 0.535). Preexisting contamination symptoms and COVID-19-related health anxiety measured by the COVID-Threat Scale did not predict relapse. Only a small proportion of patients (6%) reported COVID-19-themed obsessive-compulsive symptoms. The COVID-19 pandemic, at least in the short run, did not influence the course of illness. Twit Text FOAVip Impact of the COVID-19 Pandemic on the Short-Term Course of Obsessive-Compulsive Disorder ????J Nerv Ment Dis http://www.kidney.de/pget.php?&tw=1&pmid=33625069 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33625069 #FOAvip English Wikipedia <ref>{{Cite pmid|33625069}}</ref> Impact of the COVID-19 Pandemic on the Short-Term Course of Obsessive-Compulsive Disorder #MMPMID33625069 Sharma LP; Balachander S; Thamby A; Bhattacharya M; Kishore C; Shanbhag V; Sekharan JT; Narayanaswamy JC; Arumugham SS; Reddy JYC J Nerv Ment Dis 2021[Apr]; 209 (4): 256-264 PMID33625069show ga There is an understandable concern that obsessive-compulsive disorder (OCD) may worsen during the COVID-19 pandemic, but there are little empirical data. We report the impact of COVID-19 pandemic on the short-term course of OCD. A cohort of patients with a primary diagnosis of OCD (n = 240) who were on regular follow-up at a tertiary care specialty OCD clinic in India were assessed telephonically, about 2 months after the declaration of the pandemic ("pandemic" cohort). Data from the medical records of an independent set of patients with OCD (n = 207) who were followed up during the same period, 1 year prior, was used for comparison (historical controls). The pandemic group and historical controls did not differ in the trajectories of the Yale-Brown Obsessive-Compulsive Scale scores (chi-square likelihood ratio test of the group x time interaction = 2.73, p = 0.255) and relapse rate (21% vs. 20%; adjusted odds ratio, 0.81; 95% confidence interval, 0.41-1.59; p = 0.535). Preexisting contamination symptoms and COVID-19-related health anxiety measured by the COVID-Threat Scale did not predict relapse. Only a small proportion of patients (6%) reported COVID-19-themed obsessive-compulsive symptoms. The COVID-19 pandemic, at least in the short run, did not influence the course of illness. |Adult[MESH] |COVID-19/epidemiology/*psychology[MESH] |Case-Control Studies[MESH] |Cohort Studies[MESH] |Disease Progression[MESH] |Female[MESH] |Humans[MESH] |India/epidemiology[MESH] |Male[MESH] |Obsessive-Compulsive Disorder/epidemiology/*psychology/therapy[MESH] |Pandemics[MESH] |Recurrence[MESH] |SARS-CoV-2[MESH] |Severity of Illness Index[MESH]Impact of the COVID-19 Pandemic on the Short-Term Course of Obsessive-(epmc).pdf DeepDyve Pubget Overpricing